U.S. markets closed

  • S&P 500

    4,697.53
    +17.47 (+0.37%)
     

  • Dow 30

    36,327.95
    +203.72 (+0.56%)
     

  • Nasdaq

    15,971.59
    +31.28 (+0.20%)
     

  • Russell 2000

    2,437.08
    +34.65 (+1.44%)
     

  • Crude Oil

    81.17
    +2.36 (+2.99%)
     

  • Gold

    1,820.00
    +26.50 (+1.48%)
     

  • Silver

    24.25
    +0.33 (+1.40%)
     

  • EUR/USD

    1.1567
    +0.0009 (+0.08%)
     

  • 10-Yr Bond

    1.4530
    -0.0710 (-4.66%)
     

  • GBP/USD

    1.3502
    +0.0003 (+0.02%)
     

  • USD/JPY

    113.4000
    -0.3500 (-0.31%)
     

  • BTC-USD

    61,156.94
    -155.98 (-0.25%)
     

  • CMC Crypto 200

    1,517.93
    -22.09 (-1.43%)
     

  • FTSE 100

    7,303.96
    +24.05 (+0.33%)
     

  • Nikkei 225

    29,611.57
    -182.80 (-0.61%)
     

Stagwell Inc. Reports Equity Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

·1 min read

NEW YORK, Nov. 5, 2021 /PRNewswire/ -- Stagwell Inc. (the "Company") announced today the grant of equity inducement awards of Class A common stock to two new employees in connection with their joining the Company as agency executives. The Company granted 215,000 restricted shares to Marianne Malina, Global CEO of Crispin Porter + Bogusky, and 150,000 restricted stock units to Toby Southgate, Global CEO of Forsman & Bodenfors. The grants are effective November 1, 2021, and will vest on the third anniversary of each executive's start date, subject to continued employment. Vesting of 65,000 of the restricted shares granted to Ms. Malina is further subject to the achievement of performance conditions. The grants provide for accelerated vesting upon (i) termination of employment by the Company without Cause, with the number of shares pro-rated based on months of service, or (ii) death or disability. The Company granted these awards as a material inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4).

For more information on Stagwell, please visit www.stagwellglobal.com

About Stagwell

Stagwell is the challenger network built to transform marketing. We deliver scaled creative performance for the world's most ambitious brands, connecting culture-moving creativity with leading-edge technology to harmonize the art and science of marketing. Led by entrepreneurs, our 10,000+ specialists in 30+ countries are unified under a single purpose: to drive effectiveness and improve business results for their clients. Join us at www.stagwellglobal.com.

Contact: Beth Sidhu
Beth.Sidhu@stagwellglobal.com
202-423-4414

Stagwell is the challenger holding company built to transform marketing. (PRNewsfoto/MDC Partners Inc.,Stagwell Inc.)
Stagwell is the challenger holding company built to transform marketing. (PRNewsfoto/MDC Partners Inc.,Stagwell Inc.)
Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/stagwell-inc-reports-equity-inducement-grants-under-nasdaq-listing-rule-5635c4-301417860.html

SOURCE Stagwell Inc.

Recommended Stories

  • Why Plug Power and Nikola Dropped, But Bloom Energy Popped Today

    The fuel cells sector of the stock market is looking all shook up this morning, with shares of manufacturer Plug Power (NASDAQ: PLUG) down 2.1% and truck maker Nikola (NASDAQ: NKLA) crashing 13.7% as of 10:40 a.m. EDT. Last night after close of trading, Bloom reported a modest 3.5% gain in sales year over year for its fiscal third quarter -- $207.2 million in total. Adding to the misery, Bloom's loss when calculated according to generally accepted accounting principles (GAAP) was an even higher $0.30 per share.

  • Peloton stock is crashing -— is it time to go all in?

    Peloton's stock gets pounded after a lackluster quarter and outlook. Here's why one analyst thinks it's time to buy.

  • Why Boeing and Its Suppliers Are Up Today

    It appears airlines are about to enter a new chapter in their post-pandemic recovery, and that should be bullish for airplane demand. Shares of Boeing (NYSE: BA) traded up 5%, and key suppliers, including Spirit AeroSystems Holdings (NYSE: SPR) and Triumph Group (NYSE: TGI), were up as much as 10% on a day full of optimism about the direction of the global recovery. Airlines were hit hard by the pandemic, and their issues rippled through to aircraft manufacturers and their suppliers.

  • Why Qualcomm Stock Jumped Another 5% Today

    Shares of semiconductor giant Qualcomm (NASDAQ: QCOM), which skyrocketed yesterday on news of a big earnings beat, maintained their momentum Friday with some help from Wall Street -- rising another 5% through 11:45 a.m. EDT. At last report, a tally by TheFly.com had no fewer than five separate analysts raising price targets on Qualcomm stock yesterday, after the company reported a respectable 12% increase in revenues in its fiscal third quarter -- and a 76% raise in pro forma profits. One analyst -- Goldman Sachs -- even went ahead and upgraded Qualcomm stock to buy, with a $192 price target.

  • Why Emergent Biosolutions Stock Is Crashing Today

    Shares of Emergent Biosolutions (NYSE: EBS) have crashed 41.1% as of 11:44 a.m. EDT on Friday. The huge decline came after the company revealed on Thursday that a multimillion-dollar agreement with the U.S. Department of Health and Human Services (HHS) had been canceled. Emergent Biosolutions CEO Robert Kramer seemed to attempt to play down the termination of the HHS contract.

  • The Smartest Ultra-High-Yield Dividend Stocks to Buy With $100 Right Now

    Interestingly, some of the best deals available at the moment happen to be ultra-high-yield dividend stocks (i.e., companies with yields at or above 7%). Best of all, you don't need a boatload of cash to begin generating income or building wealth with dividend stocks. Upstream oil companies, like drillers, feel a direct pinch when crude oil or natural gas prices decline.

  • Why Dynavax Stock Is Falling Today

    Shares of the vaccine specialist Dynavax (NASDAQ: DVAX) were sliding this morning after the company reported third-quarter earnings. After the market closed on Thursday, Dynavax stock actually rose after hours on the strength of a terrific third-quarter earnings report. Yesterday, Moderna's (NASDAQ: MRNA) stock tanked after the company had to lower its revenue outlook in the face of softer vaccine demand.

  • 10 Dividend Stocks With Over 10% Yield

    In this article, we discuss the 10 dividend stocks with over 10% yield. If you want to skip our detailed analysis of these stocks, go directly to the 5 Dividend Stocks With Over 10% Yield. The Federal Reserve Bank of Dallas recently forecast that home prices and rent are likely to rise in the coming […]

  • Enbridge Reports Strong Third Quarter 2021 Results, Executing on Business Priorities

    Enbridge Inc. (Enbridge or the Company) (TSX: ENB) (NYSE: ENB) today reported third quarter 2021 financial results, reaffirmed its 2021 financial outlook, and provided a quarterly business update.

  • Merck stock's biggest selloff in nearly 17 years is cutting close to 60 points off the Dow's price

    Shares of Merck & Co. tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc. released data on a pill to treat COVID-19 that showed greater efficacy than Merck's. The stock's price decline of $8.61 was shaving about 57 points off the Dow Jones Industrial Average's price, while the Dow rallied 246 points, or 0.7%. The stock's big selloff, the stock has retraced about 56% of the gain, from the Sept. 29 close of $75.11 to

  • Why Canopy Growth Stock Crashed Today

    Canadian cannabis company Canopy Growth (NASDAQ: CGC) harshed marijuana sector investors' buzz Friday when it reported weaker than expected revenue growth in its fiscal 2022 second quarter, though it lost less money than Wall Street had forecast. As of 1:45 p.m. EDT, shares of Canopy Growth were down 14.3%, and the negative sentiment dragged on its peer pot stocks as well; Aurora Cannabis (NASDAQ: ACB) was off by 5.8%, and Tilray (NASDAQ: TLRY) was down 5.5%. To the contrary, revenues actually declined by 3% (not at all what you want to see from a growth stock), and if you net out the additional revenues contributed to the company by its recent acquisitions, revenue would have declined 13%.

  • Why Teradata Stock Fell Sharply on Friday

    Shares of cloud analytics company Teradata (NYSE: TDC) fell on Friday. Teradata stock's decline follows the company's third-quarter earnings release. While revenue and earnings per share were both ahead of analysts' consensus forecasts for the two metrics, the company missed analysts' average view for cloud annual recurring revenue.

  • Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

    ARK Invest went shopping on Thursday, buying into three stocks that have fallen after posting disappointing quarterly results this earnings season.

  • We Wouldn't Be Too Quick To Buy Exxon Mobil Corporation (NYSE:XOM) Before It Goes Ex-Dividend

    Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

  • Moderna Takes A Beating On Mounting Vaccine Challenges — Is It A Buy Or A Sell?

    Is Moderna stock a buy or a sell as it takes a beating in November on a myriad of challenges facing its Covid vaccine?

  • DocuSign, Inc. (NASDAQ:DOCU) is a Ways off From Profitability, but already has Positive Cash Flows

    When looking at DocuSign, Inc. ( NASDAQ:DOCU ), investors want to know what are the next major milestones for the company. For new companies, becoming self-sufficient signals a large reduction of bankruptcy risk, as well as that the company is creating a valuable service.

  • Here's Why Confluent Stock Is Surging Today

    Confluent's dollar-based net retention rate also exceeded 130% in the period, meaning that existing customers spent 30% more than they had in Q3 of 2020. For the full-year period, Confluent is targeting an adjusted loss between $0.90 and $0.92 on revenue between $376 million and $378 million.

  • Roku’s (NASDAQ:ROKU) Volatility should be be Expected given Optimistic Valuation

    Shares of Roku, Inc. (NASDAQ:ROKU) came under pressure on Thursday after announcing third quarter results. The results were mixed, but the company also said revenue growth would slow sharply in the fourth quarter due to supply chain constraints. Roku is priced for long term growth, and a temporary headwind shouldn’t change the long term outlook. However the stock’s high P/E ratio means investors should expect volatility for some time to come.

  • Here's Why Shares of Moderna, Novavax, and Ocugen Have All Been Extremely Volatile This Week

    Shares of COVID-19 vaccine companies Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and Ocugen (NASDAQ: OCGN) have all posted wild price fluctuations through Thursday's closing bell this week, according to data from S&P Global Market Intelligence. Specifically, Moderna's stock has fallen by 18% through the first four trading sessions this week, while Novavax's shares have plunged nearly 27% over the same period. Ocugen's stock, on the other hand, initially popped by a healthy 21.4% during Monday and Tuesday's combined trading sessions, before giving back all of these gains and then some over the next two days.

  • 1 Number Investors Might Be Overlooking From Chegg's Q3 Report

    The educational technology company expects a dreadful close to its fiscal year, but there may be a silver lining.